2016
DOI: 10.1016/j.ejpb.2016.10.017
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 50 publications
(13 citation statements)
references
References 51 publications
1
12
0
Order By: Relevance
“…PDI values ≤0.1 indicate the highest quality of dispersion. Most researchers recognize PDI values ≤0.3 as optimum values; however, values ≤0.5 are also acceptable [32]. According to literature, quality and monodisperse PLGA NPs and CS-coated PLGA NPs have been prepared.…”
Section: Resultsmentioning
confidence: 99%
“…PDI values ≤0.1 indicate the highest quality of dispersion. Most researchers recognize PDI values ≤0.3 as optimum values; however, values ≤0.5 are also acceptable [32]. According to literature, quality and monodisperse PLGA NPs and CS-coated PLGA NPs have been prepared.…”
Section: Resultsmentioning
confidence: 99%
“…As a means of drug delivery, nanoparticles could enhance the water solubility, stability, and bioavailability of drugs, so as to prolong their circulation in blood compartments 39. A study conducted by G B et al40 has indicated that the prepared nanoparticle containing a chemotherapeutic drug paclitaxel could locally release the paclitaxel at the target site to reduce the dose into the systemic circulation. Therefore, whether SNG-loaded nanocapsules can target to treat cervical cancer and improve its bioavailability needs to be further studied.…”
Section: Discussionmentioning
confidence: 99%
“…Before ex vivo and in vivo application, NC@PDA-NH 2 was dispersed in Pluronic F127-based thermosensitive hydrogel (FG) to avoid leakage which might happen if administered as a simple aqueous dispersion, and enough time was allowed for nanocrystals to interact with the mucosa. Other vehicles for nanoparticles were also reported for vaginal use, such as hydroxypropyl methylcellulose/poly(vinyl alcohol) films [31] and poly(vinyl alcohol) nanofibers [32]. FG was also applied as a vaginal formulation vehicle with good safety for many therapeutic agents.…”
Section: Resultsmentioning
confidence: 99%